BR112014020597A2 - compostos para tratar infecção por parvovírus - Google Patents

compostos para tratar infecção por parvovírus

Info

Publication number
BR112014020597A2
BR112014020597A2 BR112014020597A BR112014020597A BR112014020597A2 BR 112014020597 A2 BR112014020597 A2 BR 112014020597A2 BR 112014020597 A BR112014020597 A BR 112014020597A BR 112014020597 A BR112014020597 A BR 112014020597A BR 112014020597 A2 BR112014020597 A2 BR 112014020597A2
Authority
BR
Brazil
Prior art keywords
treat
compounds
parvovirus infection
parvovirus
infection
Prior art date
Application number
BR112014020597A
Other languages
English (en)
Inventor
Billiet Aino
Swinnen Chloë
Kiss Eleonora
Blomsma Erwin
Auwerx Joeri
Neyts Johan
Villers Jérôme
Goris Nesya
Wera Stefaan
Debeurme Veerle
Original Assignee
Aratana Therapeutics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aratana Therapeutics Nv filed Critical Aratana Therapeutics Nv
Publication of BR112014020597A2 publication Critical patent/BR112014020597A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/38Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112014020597A 2012-02-24 2013-02-22 compostos para tratar infecção por parvovírus BR112014020597A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1203180.3A GB201203180D0 (en) 2012-02-24 2012-02-24 Compounds for treating parvovirus infection
PCT/EP2013/053526 WO2013124403A1 (en) 2012-02-24 2013-02-22 Compounds for treating parvovirus infection

Publications (1)

Publication Number Publication Date
BR112014020597A2 true BR112014020597A2 (pt) 2019-09-24

Family

ID=45991646

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014020597A BR112014020597A2 (pt) 2012-02-24 2013-02-22 compostos para tratar infecção por parvovírus

Country Status (12)

Country Link
US (1) US20150018427A1 (pt)
EP (1) EP2817003A1 (pt)
JP (1) JP2015508091A (pt)
CN (1) CN104220052A (pt)
AU (1) AU2013224031A1 (pt)
BR (1) BR112014020597A2 (pt)
CA (1) CA2863851A1 (pt)
GB (1) GB201203180D0 (pt)
IN (1) IN2014DN05854A (pt)
MX (1) MX2014009950A (pt)
RU (1) RU2014138131A (pt)
WO (1) WO2013124403A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20200517A (es) * 2015-04-28 2021-01-12 Mitsubishi Tanabe Pharma Corp PROTEINA DE UNION A RGma Y SUS USO
CN109735505A (zh) * 2018-12-26 2019-05-10 河南农业大学 一株犬细小病毒毒株及其基因序列的扩增和应用
CN113121672B (zh) * 2021-04-20 2023-01-03 甘肃农业大学 猫干扰素γ的可溶性原核表达和纯化方法及应用
WO2023012329A1 (en) 2021-08-06 2023-02-09 Intervet International B.V. Method of treating veterinary viral diseases
CN116376981A (zh) * 2023-04-21 2023-07-04 西北农林科技大学 一种重组犬细小病毒假病毒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310469A (en) 1961-08-28 1967-03-21 Du Pont Pharmaceutical compositions and methods utilizing 1-aminoadamantane and its derivatives
US3257456A (en) * 1964-05-04 1966-06-21 Du Pont 2-adamantanone and derivatives
US5599998A (en) 1994-10-24 1997-02-04 Iowa State University Research Foundation, Inc. Method for the synthesis of adamantane amines
US7910620B2 (en) * 2005-04-22 2011-03-22 Broadhurst Iii Jack J Uses of neuraminidase inhibitors in infectious diseases

Also Published As

Publication number Publication date
IN2014DN05854A (pt) 2015-05-22
CN104220052A (zh) 2014-12-17
GB201203180D0 (en) 2012-04-11
RU2014138131A (ru) 2016-04-10
EP2817003A1 (en) 2014-12-31
CA2863851A1 (en) 2013-08-29
JP2015508091A (ja) 2015-03-16
AU2013224031A1 (en) 2014-07-31
MX2014009950A (es) 2015-03-20
US20150018427A1 (en) 2015-01-15
WO2013124403A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
CO7061086A2 (es) Combinaciones de compuestos activos
CO7061082A2 (es) Compuestos para tratar la artrofia muscular espinal
CO7010838A2 (es) Compuestos de imidazopirrolidinona
FR2997014B1 (fr) Composition sterile dermo-injectable
DK2895200T3 (da) Multimeriske oligonukleotidforbindelser
CO6890100A2 (es) Tratamientos de combinación para hepatitis c
CO6801733A2 (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia
BR112014000033A2 (pt) compostos para o tratamento de dependência química
BR112014028424A2 (pt) compostos de pirimidina para o tratamento de câncer
BR112013012998A2 (pt) compostos para tratar infecções por vírus sincicial respiratório
BR112013033974A2 (pt) terapia de combinação
DK2760886T3 (da) Immunocytokin-kombinationsterapi
BR112014008067A2 (pt) compostos antibacterianos
BR112015004938A2 (pt) combinações de compostos ativos
CO6791617A2 (es) Combinaciones de compuestos activos
DK2804611T3 (da) Chitosanafledte forbindelser
BR112014026553A2 (pt) Fralda descartável
BR112014020597A2 (pt) compostos para tratar infecção por parvovírus
BR112015002931A2 (pt) compostos antibacterianos
DK2917212T3 (da) Antimikrobielle midler
DE112013002564A5 (de) Nockenwelleneinheit
DK2825636T3 (da) Behandling af sædceller
BR112013023115A2 (pt) composição de tratamento capilar
BR112015011494A2 (pt) combinações de compostos ativos
CO6821942A2 (es) Combinaciones de compuestos activos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.